Chief Scientific Officer · PUMA BIOTECHNOLOGY, INC. (PBYI)

Alvin Wong

A named executive officer of PUMA BIOTECHNOLOGY in every fiscal year CompBrief holds from FY2021 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,338,769

Salary $413,683Stock awards $275,433

FY2022: $1,019,236

3rd of 5 named executive officers at Puma Biotechnology by FY2024 total.

5 named officers on file for PUMA BIOTECHNOLOGY, FY2024

Alvin Wong’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • PBYI’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PUMA BIOTECHNOLOGY’s whole pay program stands against its peers

  • PUMA BIOTECHNOLOGY’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PBYI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2025 (DEF 14A).

Free

Get Alvin Wong’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Alvin Wong compensation by year

PUMA BIOTECHNOLOGY Summary Compensation Table · all 3 fiscal years held
In US dollars, as PUMA BIOTECHNOLOGY reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2024
Salary$459,364$504,000$413,683
Bonus$96,000$115,920$0
Stock awards$84,692$104,575$275,433
Option awards$651,954$104,970$275,392
Non-equity incentive$48,000$159,667$0
Pension and deferred compensation$0$0$0
All other$22,424$30,104$374,263
Total$1,362,434$1,019,236$1,338,769

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PUMA BIOTECHNOLOGY, INC. DEF 14A filed April 28, 2025, accession 0001437749-25-013337, and prior-year filings.

How this page was built: the PUMA BIOTECHNOLOGY, INC. filed document, accession 0001437749-25-013337. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

$1.4M
$1.0M
$1.3M
FY21
FY22
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

PUMA BIOTECHNOLOGY’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Alan AuerbachPresident and Chief Executive Officer$3,969,931
Maximo NouguesChief Financial Officer$1,404,978
Alvin Wong · this pageChief Scientific Officer$1,338,769
Jeff LudwigChief Commercial Officer$1,228,288
Douglas HuntChief Regulatory Affairs, Medical Affairs, and Pharmacovigilance Officer$1,217,501

The full PUMA BIOTECHNOLOGY compensation record

free company brief

This page is one person within PUMA BIOTECHNOLOGY's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the PUMA BIOTECHNOLOGY proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PUMA BIOTECHNOLOGY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Alvin Wong's compensation dossier · One-time report. No refunds.